(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies

@inproceedings{Azoulay201613A,
  title={(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies},
  author={Elie Azoulay and Nicolas Guigue and Michael Darmon and Djamel Mokart and Virginie Lemiale and Achille Kouatchet and Julien Mayaux and François Vincent and Martine Nyunga and Fabrice Bruneel and Antoine Rabbat and St{\'e}phane Bretagne and Christine Lebert and A. P. Meert and Dominique D Benoit and Fr{\'e}d{\'e}ric P{\`e}ne},
  booktitle={Oncotarget},
  year={2016}
}
Invasive fungal infections (IFIs) are life-threatening complications of hematological malignancies that must be diagnosed early to allow effective treatment. Few data are available on the performance of serum (1-3)-β-D-glucan (BG) assays for diagnosing IFI in patients with hematological malignancies admitted to the intensive care unit (ICU). In this study… CONTINUE READING